SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-23-059162
Filing Date
2023-05-11
Accepted
2023-05-11 16:26:39
Documents
2
Group Members
DR. SENAI ASEFAWPARADIGM BIOCAPITAL ADVISORS GP LLCPARADIGM BIOCAPITAL INTERNATIONAL FUND LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2314716d1_sc13g.htm SC 13G 64914
2 EXHIBIT 1 tm2314716d1_ex-1.htm EX-99.1 4255
  Complete submission text file 0001104659-23-059162.txt   71139
Mailing Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453
Business Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Subject) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88625 | Film No.: 23911460
SIC: 8071 Services-Medical Laboratories

Mailing Address 767 THIRD AVENUE, 17TH FLOOR NEW YORK NY 10017
Business Address 767 THIRD AVENUE, 17TH FLOOR NEW YORK NY 10017 646-970-2123
Paradigm Biocapital Advisors LP (Filed by) CIK: 0001855655 (see all company filings)

IRS No.: 851451055 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G